EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?

Sven van der Woude iD, J S Klein Wassink-Ruiter, Joost Kluiver, Marthe de Jonge, Gilles F H Diercks iD

Journal of Cutaneous Pathology · 2025

DOI: 10.1111/cup.14730 ↗

At a glance

Fallbericht in Journal of Cutaneous Pathology, 2025. Written by Sven van der Woude and 4 co-authors. Institution: Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Major MEDLINE topics: Germ-Line Mutation, MAP Kinase Kinase 1, Melanoma, Noonan Syndrome. 18 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Melanocytic tumors are a diverse group of lesions and are traditionally classified based on a combination of clinical presentation as well as histological examination. More recently, molecular diagnostics has become an increasingly important part of differentiating different melanocytic lesions in the current WHO standards. This molecular testing, however, can result in unexpected findings. In this report, we describe that molecular testing of a clinical atypical melanocytic lesion showed a mutation in the MAP2K1 gene as well as an unexpected germline mutation in PTPN11 , indicative of Noonan syndrome. Based on these findings we concluded that the patient had a MAP2K1 associated melanocytic lesion with Noonan syndrome as an incidental finding. Melanomas are classically not associated with Noonan syndrome. However, we hypothesized that the germline mutations of PTPN11 and the somatic second hit mutation in the MAP2K1 genes might be involved in the formation of the aforementioned lesion. As they are both part of the RAS‐MAPK pathway. Furthermore, with the expansion of molecular diagnostics in melanomas, we expect to find an increase in unexpected (germline) mutations.

Subjects

MeSH terms (MEDLINE)

Germ-Line MutationMAP Kinase Kinase 1MelanomaNoonan SyndromeProtein Tyrosine Phosphatase, Non-Receptor Type 11Skin NeoplasmsAdultFemaleHumans

Author keywords

Noonan syndromeRAS‐MAPK pathwaymelanomamolecular pathology

Substances

MAP Kinase Kinase 1MAP2K1 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, human

Authors and institutions

  • Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Clinical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Pathology, Isala Clinics, Zwolle, The Netherlands.

ORCID profiles: Sven van der Woude, Gilles F H Diercks

Cite

APA

van der Woude, S., Klein Wassink-Ruiter, J. S., Kluiver, J., de Jonge, M., & Diercks, G. F. H. (2025). An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14730

Vancouver

van der Woude S, Klein Wassink-Ruiter JS, Kluiver J, de Jonge M, Diercks GFH. An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14730

BibTeX
@article{vanderWoude2025,
  author = {van der Woude, Sven and Klein Wassink-Ruiter, J S and Kluiver, Joost and de Jonge, Marthe and Diercks, Gilles F H},
  title = {An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  doi = {10.1111/cup.14730}
}
Start for free →